An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 8 Sponsors

No summary has been published for this bill. The full text is on the Bill text tab.

Chamber: Senate
Introduced: Jul 24, 2025
Last action: Jun 10, 2026 — Referred to Judiciary
Session: 2025-2026
Momentum: 60 · High

PASSAGE PROBABILITY

4.8% Unlikely

Why this number

Stage base Passed First Chamber — base rate 19%, measured from PA's completed sessions
Momentum +2 60/100 from the pace of recorded action
Time since last action -17 123 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.